1-13 of 13
Jun Feng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Data of Siltuximab for Chinese Patients with Imcd: Combination with BCD Regimen Benefits Severe Cases

Siyuan Li, Yuhan Gao, Yue Dang, Long Chang, Kaini Shen, Huacong Cai, Danqing Zhao, Chong Wei, Jun Feng, Lu Zhang, Jian Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 6292.
https://doi.org/10.1182/blood-2024-203586
Published: 2024
Journal Articles

A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD

Clinical Trials & Observations
Hao Zhao, Miao-yan Zhang, Kai-ni Shen, Jun Feng, Xin-xin Cao, Ming-hui Duan, Dao-bin Zhou, Lu Zhang, Jian Li
Journal: Blood
Blood (2023) 141 (21): 2654–2657.
https://doi.org/10.1182/blood.2023020009
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Lenalidomide, Anti-PD-1 Antibody Combined with Orelabrutinib or Rituximab in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Miao Qing, Yongfen Huang, Can Chen, Lingling Wang, Jun Feng, Chuanhai Xu, Yuexin Cheng, Jianming Dong, Linlin Zhang, Hao Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3769–3770.
https://doi.org/10.1182/blood-2022-167998
Published: 2022
Journal Articles

Maintenance Therapy with Single-Agent Lenalidomide for POEMS Syndrome

Yanying Yu, Xuemin Gao, Hao Zhao, Anan Li, Hao Cai, Jun Feng, Lu Zhang, Xinxin Cao, Jian Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 10118–10119.
https://doi.org/10.1182/blood-2022-158642
Published: 2022
Journal Articles

Efficacy and Safety of Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Patients with Mayo 2004 Stage 3 Light-Chain Amyloidosis: A Prospective Phase 2 Study

Ya-Juan Gao, Kaini Shen, Long Chang, Jun Feng, Yueying Mao, Lu Zhang, Xinxin Cao, Daobin Zhou, Jian Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 4391–4392.
https://doi.org/10.1182/blood-2022-157044
Published: 2022
Journal Articles

A Prospective, Multicenter Study of Bortezomib, Cyclophosphamide and Dexamethasone in Relapsed/Refractory Idiopathic Multicentric Castleman's Disease

Lu Zhang, MD, Ming-nan Jia, MD, Ai-lin Zhao, MD, Jun Feng, MD, Xin-xin Cao, MD, Yan Zhang, MD, Ming-hui Duan, MD, Dao-Bin Zhou, Yujun Dong, MD, Jian Li, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42.
https://doi.org/10.1182/blood-2020-140115
Published: 2020
Journal Articles

Methotrexate and Cytarabine for Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study

Xinxin Cao, Jian Li, MD, Ai-lin Zhao, Xue-min Gao, Hua-cong Cai, MD, Lu Zhang, MD, Yan Zhang, MD, Jun Feng, MD, Miao Chen, MD, Tie-nan Zhu, MD, Na Niu, Jian Sun, MD, Zhi-yong Liang, MD, Dao-Bin Zhou, Ming-hui Duan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 294.
https://doi.org/10.1182/blood-2019-122220
Published: 2019
Journal Articles

Home Treatment of Bortezomib: A Preliminary Exploration of a New Treatment Mode in China

Congli Zhang, Xin-xin Cao, Dong-zhu Li, Jun Feng, MD, Lu Zhang, MD, Yan Zhang, Ming-hui Duan, MD, Miao Chen, MD, Chen Yang, Wei Wang, Dao-Bin Zhou, Jian Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2127.
https://doi.org/10.1182/blood-2019-125505
Published: 2019
Journal Articles

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

Clinical Trials & Observations
Lu Zhang, Ai-lin Zhao, Ming-hui Duan, Zhi-yuan Li, Xin-xin Cao, Jun Feng, Dao-bin Zhou, Ding-rong Zhong, David C. Fajgenbaum, Jian Li
Journal: Blood
Blood (2019) 133 (16): 1720–1728.
https://doi.org/10.1182/blood-2018-11-884577
Published: 2019
Journal Articles

A Prospective Phase II Study of Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Idiopathic Multicentric Castleman's Disease

Lu Zhang, MD, Ai-lin Zhao, MD, Jun Feng, MD, Xinxin Cao, MD, Yan Zhang, MD, Tienan Zhu, MD, Minghui Duan, MD, Daobin Zhou, MD, Jian Li, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4142.
https://doi.org/10.1182/blood-2018-99-113528
Published: 2018
Journal Articles

Survival Comparison of Three Treatment Regimens of POEMS Syndrome: A Single-Center Retrospective Study

Hao Zhao, MD, Xufei Huang, MD, Hao Cai, Lu Zhang, Jun Feng, MD, Xinxin Cao, Daobin Zhou, Jian Li, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3428.
https://doi.org/10.1182/blood-2018-99-111687
Published: 2018
Journal Articles

Bortezomib-Based Chemotherapy Reduces Early Mortality and Improves Outcomes in Patients with Ultra-High-Risk Light-Chain Amyloidosis

Kaini Shen, Congli Zhang, Jun Feng, MD, Lu Zhang, Xinxin Cao, Daobin Zhou, MD, Jian Li, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3304.
https://doi.org/10.1182/blood-2018-99-112407
Published: 2018
Journal Articles

Cerebral Aneurysm Bleeding Due to Disseminated Fusarium Infection in a Patient with Acute Monocytic Leukemia

Shenxian Qian, MD, Da-quan Gao, MD, Tan Jun-feng, MD
Journal: Blood
Blood (2011) 118 (21): 4736.
https://doi.org/10.1182/blood.V118.21.4736.4736
Published: 2011